SE7811323L - Nya kinazolinderivat med terapeutisk aktivitet - Google Patents

Nya kinazolinderivat med terapeutisk aktivitet

Info

Publication number
SE7811323L
SE7811323L SE7811323A SE7811323A SE7811323L SE 7811323 L SE7811323 L SE 7811323L SE 7811323 A SE7811323 A SE 7811323A SE 7811323 A SE7811323 A SE 7811323A SE 7811323 L SE7811323 L SE 7811323L
Authority
SE
Sweden
Prior art keywords
new
therapeutic activity
chinazoline derivatives
chinazoline
derivatives
Prior art date
Application number
SE7811323A
Other languages
English (en)
Swedish (sv)
Inventor
S F Campbell
J C Danilewicz
A L Ham
J K Stubbs
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7811323L publication Critical patent/SE7811323L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
SE7811323A 1977-11-03 1978-11-01 Nya kinazolinderivat med terapeutisk aktivitet SE7811323L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4566977 1977-11-03

Publications (1)

Publication Number Publication Date
SE7811323L true SE7811323L (sv) 1979-05-04

Family

ID=10438111

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7811323A SE7811323L (sv) 1977-11-03 1978-11-01 Nya kinazolinderivat med terapeutisk aktivitet

Country Status (24)

Country Link
US (1) US4188391A (fr)
JP (1) JPS5498786A (fr)
AR (2) AR221851A1 (fr)
AT (1) AT366043B (fr)
AU (1) AU506317B2 (fr)
BE (1) BE871769A (fr)
CA (1) CA1086735A (fr)
CH (1) CH637130A5 (fr)
DE (1) DE2847622A1 (fr)
DK (1) DK488078A (fr)
ES (2) ES474763A1 (fr)
FI (1) FI63934C (fr)
FR (1) FR2407926A1 (fr)
HK (1) HK94184A (fr)
IE (1) IE47996B1 (fr)
IL (1) IL55845A (fr)
IT (1) IT1101287B (fr)
KE (1) KE3351A (fr)
LU (1) LU80461A1 (fr)
MY (1) MY8500284A (fr)
NL (1) NL174144C (fr)
PH (1) PH14693A (fr)
PT (1) PT68733A (fr)
SE (1) SE7811323L (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
CA2148260A1 (fr) * 1993-09-10 1995-03-16 Yasutaka Takase Composes a base de quinazoline
US6518423B1 (en) 1996-08-09 2003-02-11 Eisai Co., Ltd. Benzopiperidine derivatives
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
EP2314289A1 (fr) 2005-10-31 2011-04-27 Braincells, Inc. Modulation de la neurogenese dont la médiation est assurée par récepteur gaba
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2643199A1 (fr) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation de neurogenese par des agents nootropes
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
CA2651862A1 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenese induite par le recepteur 5ht
WO2008030651A1 (fr) * 2006-09-08 2008-03-13 Braincells, Inc. Combinaisons contenant un dérivé de 4-acylaminopyridine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
EP2074111A2 (fr) * 2006-10-06 2009-07-01 Bausch & Lomb Incorporated Acides carboxyliques de quinolone, dérivés de ceux-ci et leurs procédés de préparation et d'utilisation
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (fr) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation
JP7688912B2 (ja) * 2019-03-19 2025-06-05 スティングレイ・セラピューティクス・インコーポレイテッド キノリンおよびキナゾリン化合物およびその使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812127A (en) * 1966-10-31 1974-05-21 Pfizer 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters
GB1199768A (en) * 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
IT7829368A0 (it) 1978-11-02
ES480053A1 (es) 1980-07-16
JPS5498786A (en) 1979-08-03
JPS566428B2 (fr) 1981-02-10
AT366043B (de) 1982-03-10
CH637130A5 (de) 1983-07-15
CA1086735A (fr) 1980-09-30
AU506317B2 (en) 1979-12-20
DK488078A (da) 1979-05-04
MY8500284A (en) 1985-12-31
FR2407926B1 (fr) 1982-11-12
IE47996B1 (en) 1984-08-22
HK94184A (en) 1984-12-07
IL55845A (en) 1982-07-30
KE3351A (en) 1983-12-16
PT68733A (en) 1978-12-01
ATA783878A (de) 1981-07-15
AU4127778A (en) 1979-05-17
AR221851A1 (es) 1981-03-31
PH14693A (en) 1981-11-10
LU80461A1 (fr) 1980-05-07
FI63934C (fi) 1983-09-12
IL55845A0 (en) 1979-01-31
FI63934B (fi) 1983-05-31
FR2407926A1 (fr) 1979-06-01
DE2847622A1 (de) 1979-05-31
BE871769A (fr) 1979-05-03
IT1101287B (it) 1985-09-28
AR221251A1 (es) 1981-01-15
US4188391A (en) 1980-02-12
NL7810865A (nl) 1979-05-07
FI783325A7 (fi) 1979-05-04
NL174144C (nl) 1984-05-01
NL174144B (nl) 1983-12-01
ES474763A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
SE7806710L (sv) Nya karbostyrilderivat
SE7811323L (sv) Nya kinazolinderivat med terapeutisk aktivitet
SE7810613L (sv) Nya fenyletanolderivat
FI781614A7 (fi) Terapeutiska aemnen
FI781613A7 (fi) Terapeutiska hydantoinfoereningar
FI780784A7 (fi) Transportbehaollare med anordning foer tippning i sidled
SE7802867L (sv) Nya 4-acylamino-fenyl-etanolaminer
FI781032A7 (fi) Plastroer med laongsriktade kanaler i vaeggen
SE7807642L (sv) Nya 1-acyl-2-cyanaziridiner
SE7812268L (sv) Fenylglycinderivat med terapeutisk verkan
SE7811322L (sv) Nya derivat av ftalazin med terapeutisk aktivitet
FI54629C (fi) Foerfarande i en med en genomstroemningstork foersedd tissuepappersmaskin
SE7811457L (sv) Nya kinolylguanidinderivat
FI780816A7 (fi) Behaollare med en daer i befintlig utbytbar bandkassett
SE7800739L (sv) Nya aminoalkoxifenylderivat
FI782909A7 (fi) Nya 7-azabenzimidazoler med basiska sidokedjor
BE870634A (fr) Agents therapeutiques antiallergiques
FI782011A7 (fi) Nya imidazo-isokinolin-dioner
FI782250A7 (fi) Nya antagonistiska angiotensin ii-analoger med en alfa-aminooxisyra i 1-staellningen
DK35978A (da) Furanderivater med fungcid aktivitet
FI780350A7 (fi) Nya terapeutiska medel
FI782451A7 (fi) Tretrycksstyrventil i en indirekt fungerande tryckluftsbroms med accelerationsventil
SE7804318L (sv) Nya naftyridiner
FI781510A7 (fi) Katodstraoleroer med minskade spaenningar i en med slitsformiga oeppningar foersedd haolskiva
FI781397A7 (fi) Nya fenylglycin-derivat